AKT1 and cancer: The most well-characterized example of this is in cancer, and recent studies have suggested that PHLPP2 is abnormally expressed in multiple human cancers and may act as a tumor suppressor gene by inhibiting prosurvival signaling pathways, such as PI3K/Akt 8, 9.